MaxCyte Inc

Research MaxCyte Inc (MXCT) on Bullrun: market cap USD 132.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMXCT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 132.83M
• Financial periodFY2025
• RevenueUSD 20.96M
• Revenue growth-5.7%
• Net income-USD 44.63M
• Free cash flow-USD 36.18M
• Gross margin127.9%

Valuation Snapshot

latest market cap is USD 132.83M.

About MaxCyte Inc

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications;

Frequently asked questions

What is MaxCyte Inc's market cap?

MaxCyte Inc's market capitalization is USD 132.83M.

What does MaxCyte Inc do?

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection;